CFM
Catalyst Funds Management Portfolio holdings
AUM
$362M
1-Year Return
42.71%
This Quarter Return
-3.7%
1 Year Return
+42.71%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$382M
AUM Growth
-$22.3M
(-5.5%)
Cap. Flow
-$13.2M
Cap. Flow
% of AUM
-3.45%
Top 10 Holdings %
Top 10 Hldgs %
18.96%
Holding
611
New
314
Increased
64
Reduced
61
Closed
162
Top Buys
| 1 |
NVIDIA
NVDA
|
$13.1M |
| 2 |
Pfizer
PFE
|
$7.17M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$5.18M |
| 4 |
Blackrock
BLK
|
$5.07M |
| 5 |
eBay
EBAY
|
$4.8M |
Top Sells
| 1 |
Broadcom
AVGO
|
$35.5M |
| 2 |
Meta Platforms (Facebook)
META
|
$32.4M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
$11.4M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
$10.7M |
| 5 |
Cisco
CSCO
|
$8.73M |
Sector Composition
| 1 | Financials | 17.62% |
| 2 | Technology | 15.49% |
| 3 | Industrials | 13.5% |
| 4 | Healthcare | 12.12% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Rezolute
RZLT
$696M
| $31.3K | 0.01% |
+10,779
| New | +$31.3K |
|
427
Origin Materials
ORGN
$77.7M
| $30.7K | 0.01% |
46,320
+16,320
| +54% | +$10.8K |
|
|
USAS
428
Americas Gold and Silver
USAS
$747M
| $30.4K | 0.01% |
23,040
| – | – |
|
429
Genelux
GNLX
$127M
| $30.3K | 0.01% |
+11,238
| New | +$30.3K |
|
430
Douglas Elliman
DOUG
$257M
| $30.3K | 0.01% |
+17,635
| New | +$30.3K |
|
431
Inhibikase Therapeutics
IKT
$124M
| $30K | 0.01% |
+13,712
| New | +$30K |
|
432
Vuzix
VUZI
$188M
| $29.2K | 0.01% |
14,300
+2,300
| +19% | +$4.69K |
|
433
Zevia
ZVIA
$193M
| $27.4K | 0.01% |
+12,707
| New | +$27.4K |
|
434
Relay Therapeutics
RLAY
$710M
| $26.5K | 0.01% |
+10,100
| New | +$26.5K |
|
435
Aclaris Therapeutics
ACRS
$227M
| $25.5K | 0.01% |
16,698
+2,698
| +19% | +$4.13K |
|
436
Genasys
GNSS
$89.4M
| $23.8K | 0.01% |
+10,496
| New | +$23.8K |
|
437
Annexon
ANNX
$238M
| $22.7K | 0.01% |
+11,760
| New | +$22.7K |
|
438
Allogene Therapeutics
ALLO
$255M
| $21.3K | 0.01% |
+14,580
| New | +$21.3K |
|
|
ILLR
439
Triller Group Inc. Common Stock
ILLR
$65.1M
| $21.1K | 0.01% |
+27,071
| New | +$21.1K |
|
440
Alto Ingredients
ALTO
$90.6M
| $20K | 0.01% |
+17,557
| New | +$20K |
|
441
SmartRent
SMRT
$275M
| $18.7K | ﹤0.01% |
15,428
-12,572
| -45% | -$15.2K |
|
442
Taysha Gene Therapies
TSHA
$917M
| $16.5K | ﹤0.01% |
+11,900
| New | +$16.5K |
|
443
Kopin
KOPN
$345M
| $16.5K | ﹤0.01% |
+17,710
| New | +$16.5K |
|
444
Microvision
MVIS
$334M
| $12.5K | ﹤0.01% |
+10,100
| New | +$12.5K |
|
|
VXRT
445
DELISTED
Vaxart
VXRT
| $10.9K | ﹤0.01% |
+26,742
| New | +$10.9K |
|
446
Senseonics Holdings
SENS
$373M
| $10.1K | ﹤0.01% |
+15,400
| New | +$10.1K |
|
447
Babcock & Wilcox
BW
$215M
| $9.74K | ﹤0.01% |
14,484
-516
| -3% | -$347 |
|
448
Vor Biopharma
VOR
$248M
| $7.72K | ﹤0.01% |
+10,764
| New | +$7.72K |
|
449
TSMC
TSM
$1.26T
| – | – |
-4,600
| Closed | -$908K |
|
450
Twilio
TWLO
$16.7B
| – | – |
-2,000
| Closed | -$216K |
|